Latest 10-K annual reports

Akoya Biosciences files an amendment to its 2024 Annual Report on Form 10-K to include information required by Part III, covering directors, executive officers, compensation, and corporate governance.
Redfin Corporation files an amendment to its 2024 annual report to include Part III information regarding directors, executive officers, and corporate governance, initially omitted in reliance on General Instruction G(3) to Form 10-K.
NASDAQ
Golden Entertainment files an amendment to its 2024 Form 10-K solely to correct the date of the former auditor's opinion.
NYSE
System1, Inc. files an amendment to its 2024 annual report on Form 10-K to include information on directors, executive compensation, and related matters previously intended to be incorporated by reference from a proxy statement.
NASDAQ
Wrap Technologies files an amendment to its 2024 annual report on Form 10-K to include information regarding directors, executive officers, corporate governance, and executive compensation.
NASDAQ
Creative Medical Technology Holdings files an amendment to its 2024 annual report, providing updates on executive compensation, director information, related party transactions, and other corporate governance matters.
OQB
Glidelogic Corp.'s Form 10-K filing reveals a year of diversified software development and consulting efforts in AI, FinTech, and blockchain, with revenue growth and ongoing concerns about the company's ability to continue as a going concern.
180 Life Sciences Corp. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted disclosures regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.
NASDAQ
RCM Technologies files an amendment to its annual report to include information previously intended to be incorporated by reference from the company's proxy statement.
Kronos Bio files an amendment to its 2024 Form 10-K to include Part III information regarding directors, executive officers, compensation, and related matters.
Paramount Global files an amendment to its 2024 annual report, providing detailed information on directors, executive compensation, corporate governance, and related matters.
NASDAQ
Jazz Pharmaceuticals files an amendment to its 2024 Annual Report on Form 10-K to include information previously intended to be incorporated by reference from its proxy statement.
NASDAQ
Inhibikase Therapeutics files an amendment to its annual report to include previously omitted information regarding directors, executive officers, corporate governance, executive compensation, and related matters.
NASDAQ
Savara Inc. files an amendment to its annual report on Form 10-K to include its Insider Trading and Disclosure Policy, which was inadvertently omitted from the original filing.
NASDAQ
ClearOne Inc. filed an amendment to its annual report on Form 10-K to include its policy for the recovery of erroneously awarded compensation, which was inadvertently omitted from the original filing.
NASDAQ
Trimble Inc. announces its 10-K filing for fiscal year 2024, highlighting strategic divestitures, revenue shifts, and ongoing efforts to address internal control weaknesses amidst a challenging global economic landscape.
NASDAQ
MIND Technology, Inc. reports improved financial results for fiscal year 2025, driven by growth in its Seamap Marine Products business and cost-saving initiatives.
OQB
Marvion Inc.'s 10-K filing reveals a year of transition, marked by the acquisition of UWMC, a shift in business focus to logistics and warehousing, and ongoing navigation of complex regulatory risks in Hong Kong.
Neuralbase AI Ltd. reports its annual results on Form 10-K, highlighting its development-stage AI platform, Multidoc.ai, designed for intelligent document processing.
NASDAQ
Village Farms International files an amendment to its 2024 Annual Report on Form 10-K to include information required in Part III and update the Exhibit Index.
OID
NetBrands Corp.'s 2024 annual report reveals a substantial revenue decrease and a net loss, raising concerns about the company's ability to continue as a going concern.
NYSE
Mesabi Trust's fiscal year 2025 saw a significant increase in net income, driven by an arbitration award and higher royalty income, leading to substantially increased distributions to unitholders.
OQB
Kinetic Seas Inc. files its Form 10-K, reporting $210,584 in consulting revenue but a net loss of $3,897,122 for the year ended December 31, 2024, while also expressing substantial doubt about its ability to continue as a going concern.
NYSE
MarineMax, Inc. filed an amendment to its annual report on Form 10-K to include certain XBRL Interactive Data that was inadvertently omitted from the original filing.
NASDAQ
Apogee Enterprises announces its fiscal year 2025 results, highlighting strategic progress and unveiling a new phase of its cost efficiency program.
NASDAQ
Helen of Troy's fiscal 2025 results reveal a decrease in net sales and operating income, impacted by a $51.5 million asset impairment charge and restructuring costs.
OQB
BIO-key International's 10-K filing reveals a strategic shift towards higher-margin license sales and cost reductions, despite a revenue decrease.
OID
TurnOnGreen, Inc. reports increased revenue and gross profit for fiscal year 2024, driven by growth in the defense sector and strategic focus on EV charging solutions.
NASDAQ
Boxlight Corporation files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive officers, corporate governance, and updated certifications.
NASDAQ
Alumis Inc. files an amendment to its 2024 Annual Report on Form 10-K to include Part III information and update certain disclosures.